{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:42:12Z","timestamp":1790811732599,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.hoc.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T19:34:44Z","timestamp":1510947284000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Michelle L.","family":"Mauermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.hoc.2017.09.012_bib1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2017.09.012_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2017.09.012_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","article-title":"Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP","volume":"83","author":"Mauermann","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"19","key":"10.1016\/j.hoc.2017.09.012_bib4","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1212\/WNL.0000000000001565","article-title":"Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome","volume":"84","author":"Karam","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.hoc.2017.09.012_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.hoc.2017.09.012_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ajh.24171","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"90","author":"Dispenzieri","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.21707","article-title":"Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome","volume":"85","author":"Stankowski-Drengler","year":"2010","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.hoc.2017.09.012_bib8","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2010-11-316935","article-title":"Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients","volume":"117","author":"Dao","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.012_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/mus.24768","article-title":"Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Naddaf","year":"2015","journal-title":"Muscle Nerve"},{"issue":"17","key":"10.1016\/j.hoc.2017.09.012_bib10","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib11","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.3324\/haematol.2013.102962","article-title":"Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndrome","volume":"99","author":"Wang","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/WNL.0b013e318263c42b","article-title":"Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome","volume":"79","author":"Kanai","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.hoc.2017.09.012_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.24267","article-title":"Motor nerve conduction study and muscle strength in newly diagnosed POEMS syndrome","volume":"51","author":"Liu","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.012_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/mus.25250","article-title":"Blink reflex role in algorithmic genetic testing of inherited polyneuropathies","volume":"55","author":"Wang","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hoc.2017.09.012_bib15","article-title":"Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy","author":"Wang","year":"2017","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00256-017-2607-8","article-title":"Osteolytic-variant POEMS syndrome: an uncommon presentation of \u201costeosclerotic\u201d myeloma","volume":"46","author":"Clark","year":"2017","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.hoc.2017.09.012_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00330-014-3428-y","article-title":"Computed tomography assessment of bone lesions in patients with POEMS syndrome","volume":"25","author":"Glazebrook","year":"2015","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.hoc.2017.09.012_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.115.160507","article-title":"Characterizing POEMS syndrome with 18F-FDG PET\/CT","volume":"56","author":"Pan","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hoc.2017.09.012_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2017.05.019","article-title":"Diagnostic challenges in POEMS syndrome presenting with polyneuropathy: a case series","volume":"378","author":"Li","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"issue":"12","key":"10.1016\/j.hoc.2017.09.012_bib20","first-page":"1127","article-title":"Uncompacted myelin lamellae and nodal ion channel disruption in POEMS syndrome","volume":"74","author":"Hashimoto","year":"2015","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"11","key":"10.1016\/j.hoc.2017.09.012_bib21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"issue":"9002","key":"10.1016\/j.hoc.2017.09.012_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet"},{"issue":"Pt 8","key":"10.1016\/j.hoc.2017.09.012_bib23","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.hoc.2017.09.012_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-016-0389-1","article-title":"Nerve pathologic features differentiate POEMS syndrome from CIDP","volume":"4","author":"Piccione","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"24","key":"10.1016\/j.hoc.2017.09.012_bib25","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","article-title":"Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2017.09.012_bib26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3109\/10428194.2013.869329","article-title":"Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis","volume":"55","author":"Zagouri","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.hoc.2017.09.012_bib27","article-title":"Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen","author":"He","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib28","first-page":"627","article-title":"New strategy of treatment for POEMS syndrome\u2013autologous peripheral blood stem cell transplantation and thalidomide therapy","volume":"60","author":"Kuwabara","year":"2008","journal-title":"Brain Nerve"},{"issue":"11","key":"10.1016\/j.hoc.2017.09.012_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23291","article-title":"The clinical spectrum of Castleman's disease","volume":"87","author":"Dispenzieri","year":"2012","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1016\/j.hoc.2017.09.012_bib30","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1212\/WNL.0000000000003405","article-title":"Clinical spectrum of Castleman disease-associated neuropathy","volume":"87","author":"Naddaf","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib32","first-page":"379","article-title":"Angiofollicular lymph node hyperplasia and peripheral neuropathy: association with monoclonal gammopathy","volume":"57","author":"Hineman","year":"1982","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.hoc.2017.09.012_bib33","first-page":"525","article-title":"Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis","volume":"5","author":"Menke","year":"1992","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.012_bib34","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.012_bib35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<788::AID-CNCR18>3.0.CO;2-P","article-title":"Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus","volume":"80","author":"Chadburn","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.012_bib36","first-page":"1517","article-title":"Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease","volume":"151","author":"Parravicini","year":"1997","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2017.09.012_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/mp.53.2.69","article-title":"Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?","volume":"53","author":"O'Leary","year":"2000","journal-title":"Mol Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2017.09.012_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1440-1827.2001.01266.x","article-title":"HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease","volume":"51","author":"Suda","year":"2001","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.hoc.2017.09.012_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-200301000-00010","article-title":"Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease","volume":"27","author":"Amin","year":"2003","journal-title":"Am J Surg Pathol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:05:12Z","timestamp":1760184312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858817301521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0889858817301521"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2017.09.012","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}